PCSA Processa Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$1,61
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,5752 haftanın en düşüğü
$14,2552 haftanın en yükseği
Piyasa Değeri (MRQ)
$4M
P/E
-0.3
Hisse Başına Kâr
$-10.36
rozetleriniz
52 Haftlık Aralık
$2–$14
Analist Derecelendirmesi
BUY
Fiyat Hedefi
·
P/E
-0.3
ROE
·
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
PCSA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.61
Piyasa Değeri (MRQ)
$4M
P/E
-0.3
Hisse Başına Kâr
$-10.36
52 Haftlık Aralık
$2–$14
PCSA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 17 Aralık 2025 | 1-for-25 | Ters |
| 22 Ocak 2024 | 1-for-20 | Ters |
| 23 Aralık 2019 | 1-for-7 | Ters |
| 08 Aralık 2017 | 1-for-7 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir·2021-12-31 → 2022-12-31
Hisse Başına Kâr$-10.362016-12-31 → 2025-12-31
Serbest Nakit Akışı·2023-12-31 → 2024-12-31
Net kar marjı·2016-12-31 → 2016-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PCSA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -0.35Y ort. ≈-0.4 | ≈-0.4 | · | · | |
| F/D (MRQ) | -14.25Y ort. ≈17.0 | ≈17.0 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 1.35Y ort. ≈28.1 | ≈28.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PCSA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 0.95Y ort. ≈5.8 | ≈5.8 | 3.0 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
4.5%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 31 Aralık 2025 | $-2.57 | $-1.53 | -68.0% | |
| 30 Eylül 2025 | $-1.75 | $-2.04 | 14.2% | |
| 30 Haziran 2025 | $-6.25 | $-5.87 | -6.6% | |
| 31 Mart 2025 | $-7.50 | $-19.64 | 61.8% | |
| 31 Aralık 2024 | $-18.50 | $-23.46 | 21.1% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $0 | · | · | · | · | · | $113.4K | $107.2K | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | $125.9K | $66.8K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | $5.0K | $-12.5K | $40.4K | |
| R&D Expense | · | · | $6M | $11M | $7M | $3M | $2M | $3M | $964.2K | $2M | $29.2K | $178.1K | |
| SG&A Expense | $6M | $5M | $6M | $9M | $5M | $3M | $2M | $1M | $838.3K | $70.0K | $945.5K | $2M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $2M | $2M | $3M | $3M | |
| Operating Income | $-14M | $-12M | $-11M | $-28M | $-12M | $-15M | $-4M | $-5M | $-2M | $-2M | · | · | |
| Interest Expense | · | · | · | · | $362 | $281.1K | $36.7K | $161.2K | $59.1K | · | $235.6K | $315.3K | |
| Interest Income | $109.5K | $201.1K | $335.5K | $101.2K | $11.6K | $3.2K | $11.5K | $18.3K | $5.2K | $4.5K | $4.7K | $155 | |
| Pretax Income | $-14M | $-12M | $-11M | $-27M | $-12M | $-15M | $-4M | $-5M | $-2M | $-337.2K | $-3M | $-4M | |
| Income Tax | · | · | · | · | $-530.6K | $-1M | $-602.7K | $-902.8K | $258.6K | · | $-100 | $-100 | |
| Net Income | $-14M | $-12M | $-11M | $-27M | $-11M | $-14M | $-3M | $-4M | $-2M | $-2M | $-3M | $-5M | |
| EPS (Basic) | $-10.36 | $-96.78 | $-8.48 | $-34.05 | $-0.75 | · | · | · | $-0.06 | $-0.07 | · | · | |
| EPS (Diluted) | $-10.36 | $-96.78 | $-8.48 | $-34.05 | · | · | · | · | $-0.06 | $-0.07 | · | · | |
| Shares (Basic) | 1,309,271 | 122,438 | 1,311,572 | 805,477 | 15,319,463 | · | · | · | 32,595,680 | 29,321,049 | · | · | |
| Shares (Diluted) | 1,309,271 | 122,438 | 1,311,572 | 805,477 | · | · | · | · | 32,595,680 | 29,321,049 | · | · | |
| EBITDA | · | $-12M | $-11M | $-28M | · | · | $-4M | $-5M | · | · | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $1M | $5M | $7M | $16M | $15M | $691.5K | $2M | $3M | $1M | $2.1K | $21.2K | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $219.2K | |
| Prepaid Expense | $133.9K | $687.8K | $926.3K | $2M | $2M | $554.7K | $315.6K | $257.8K | $41.4K | $18.1K | $47.7K | $107.9K | |
| Current Assets | $6M | $2M | $6M | $8M | $18M | $16M | $1M | $2M | $3M | $2M | $104.2K | $383.0K | |
| PP&E (Net) | $3.8K | $5.0K | $2.6K | · | · | $484 | $8.9K | $17.4K | $25.8K | $22.4K | $159 | $359.0K | |
| PP&E (Gross) | · | · | · | · | $29.1K | $29.1K | $29.1K | $29.1K | $29.1K | $23.8K | $19.1K | $507.1K | |
| Accum. Depreciation | · | · | · | · | $29.1K | $28.6K | $20.1K | $11.7K | $3.2K | $1.4K | $-19.0K | $-148.2K | |
| Intangibles | · | · | · | · | $8M | $9M | $10M | $10M | · | · | · | · | |
| Other Non-current Assets | · | · | $5.5K | $5.5K | $5.5K | $9M | $10M | $10M | $5.5K | $5.5K | · | · | |
| Total Assets | $8M | $3M | $6M | $9M | $26M | $25M | $11M | $12M | $3M | $2M | $104.3K | $3M | |
| Accounts Payable | $1M | $880.9K | $311.6K | $327.5K | $218.9K | $320.7K | $75.6K | $292.1K | $50.7K | $14.6K | $159.2K | $153.9K | |
| Accrued Liabilities | $1M | $578.7K | $146.3K | $403.1K | $279.3K | $224.7K | $213.2K | $103.3K | $64.4K | $83.0K | $95.3K | $94.2K | |
| Short-term Debt | · | · | · | · | · | $117.6K | · | · | · | $962.4K | $947.4K | $160.0K | |
| Current Liabilities | $2M | $2M | $730.6K | $998.6K | $971.0K | $1M | $1M | $645.7K | $3M | $97.7K | $2M | $843.9K | |
| Capital Leases | · | · | $66.9K | $150.6K | $7.4K | $78.5K | $147.4K | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | $530.6K | $2M | $2M | · | · | · | · | |
| Total Liabilities | $2M | $2M | $797.5K | $1M | $978.4K | $2M | $3M | $3M | $3M | $97.7K | $2M | $1M | |
| Total Debt | · | · | · | · | · | · | · | · | · | $962.4K | $947.4K | $160.0K | |
| Common Stock | $257 | $15 | $129 | $80 | $1.6K | $1.4K | $549 | $552 | $3.5K | $3.2K | $1.1K | $1.1K | |
| Paid-in Capital | · | · | · | · | · | $48M | $19M | $19M | $4M | $4M | $14M | $14M | |
| Retained Earnings | $-101M | $-87M | $-75M | $-64M | $-37M | $-25M | $-11M | $-8M | $-4M | $-2M | $-15M | $-12M | |
| Treasury Stock | $300.0K | $300.0K | $300.0K | $300.0K | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $6M | $2M | $5M | $7M | $25M | $23M | $8M | $10M | $373.2K | $-2M | $-85.7K | $1M | |
| Liabilities + Equity | $8M | $3M | $6M | $9M | $26M | $25M | $11M | $12M | $3M | $2M | $104.3K | $3M | |
| Shares Outstanding | 2,571,914 | 148,108 | 1,286,000 | 801,774 | 15,710,246 | 14,181,734 | 5,486,595 | 5,525,009 | 35,272,626 | 31,745,242 | 11,017,388 | 10,952,356 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $857.5K | $629.5K | $1M | $9M | $3M | $3M | $510.5K | $74.1K | · | $6.7K | $96.9K | $231.5K | |
| Deferred Tax | · | · | · | · | $-530.6K | $-1M | $-602.7K | $-902.8K | $-166.8K | · | · | · | |
| Amort. of Intangibles | · | · | · | $788.5K | $790.5K | $795.3K | $795.3K | $621.6K | · | · | $178.6K | $357.1K | |
| Operating Cash Flow | $-11M | $-11M | $-8M | $-10M | $-9M | $-3M | $-3M | $-4M | $-2M | $-2M | $-871.9K | $-3M | |
| CapEx | · | $3.2K | $2.8K | · | · | · | · | · | $20.6K | $23.8K | $1.4K | $11.0K | |
| Investing Cash Flow | $-850.0K | $-3.2K | $-2.8K | · | · | · | · | $-22.3K | $1M | $-1M | $40.2K | $-44.9K | |
| Stock Issued | $17M | $8M | $6M | · | $10M | $17M | · | $3M | · | $4M | $88.0K | $366.3K | |
| Net Stock Activity | · | $8M | $6M | $6M | · | · | · | $3M | · | · | $88.0K | $366.3K | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $42.9K | $45.6K | |
| Financing Cash Flow | $17M | $8M | $6M | $-388.8K | $10M | $18M | $2M | $3M | $2M | $4M | $821.1K | $3M | |
| Net Change in Cash | $4M | $-4M | $-2M | $-10M | $1M | $15M | $-1M | $-1M | $2M | $1M | $-10.6K | $-161.8K | |
| Free Cash Flow | · | $-11M | $-8M | · | · | · | · | · | · | · | $-873.3K | $-3M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-1M | $-2M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | 100.0% | -11.0% | 43.4% | |
| Net Margin | · | · | · | · | · | · | · | · | · | -6719.6% | -2957.2% | -2260.8% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | -6743.6% | -2629.8% | -2260.8% | |
| ROA | · | -262.9% | -154.4% | -156.3% | · | · | -28.7% | -48.7% | · | -624.8% | -253.1% | -165.2% | |
| ROE | · | -437.5% | -183.0% | -222.0% | · | · | -40.2% | -37.3% | · | 27.6% | 870.2% | -314.4% | |
| ROIC | · | · | · | · | · | · | -41.6% | -37.6% | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.2 | 7.7 | 8.4 | · | · | 0.8 | 3.1 | · | 0.0 | 0.1 | 0.5 | |
| Quick Ratio | · | 0.8 | 6.4 | 6.5 | · | · | 0.6 | 2.7 | · | 0.0 | 0.0 | 0.0 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | -0.4 | -0.5 | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | -107.4 | -28.1 | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | · | · | · | · | · | 0.1 | 0.1 | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.5 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.46 | $3.88 | $0.47 | · | · | $1.46 | $0.25 | · | $-0.21 | $-0.18 | $0.11 | |
| Cash Flow / Share | · | $-3.67 | $-6.15 | · | · | · | · | · | · | · | · | · | |
| Cash / Share | · | $0.32 | $3.66 | $0.41 | · | · | $0.13 | $0.04 | · | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-10.36 | $-96.78 | $-8.48 | $-34.05 | · | · | · | · | $-0.06 | $-0.07 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $0 | $0 | $168.6K | $168.6K | $168.6K | $168.6K | $168.6K | $113.4K | $107.2K | |
| Net Income TTM | $-14M | $-12M | $-11M | $-27M | $-11M | $-14M | $-3M | $-4M | $-2M | $-2M | $-3M | $-5M | |
| Market Cap | · | $3M | $9M | $353M | · | · | $1.98B | $19.49B | · | $2.70B | $4.34B | $23.61B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $2.70B | $4.34B | $23.61B | |
| P/E | -0.3 | -0.0 | -0.8 | -0.6 | · | · | · | · | -10266.7 | -3500.0 | · | · | |
| P/S | · | · | · | · | · | · | 11715.9 | 115619.5 | · | 16011.2 | 38228.6 | 220193.0 | |
| P/B | · | 1.9 | 1.7 | 47.2 | · | · | 246.5 | 2009.3 | · | -1148.1 | -2191.3 | 19548.5 | |
| P / Tangible Book | 1.3 | 1.9 | 1.7 | 47.2 | 88.3 | 132.8 | · | · | · | · | · | · | |
| P / Cash Flow | · | -0.3 | -1.1 | -36.7 | · | · | -718.2 | -5256.8 | · | -62478.5 | -4973.1 | -8760.4 | |
| P / FCF | · | -0.3 | -1.1 | · | · | · | · | · | · | · | -4965.1 | -8606.2 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | -4966.2 | -8606.3 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 16016.9 | 38236.9 | 220194.3 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Earnings Yield | -359.7% | -10948.0% | -126.6% | -154.8% | · | · | · | · | -0.01% | -0.03% | · | · | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | -1.3% | · | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $42.9K | $45.6K |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $3M | $3M | |
| Operating Income | $-2M | $-3M | $-4M | $-3M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-4M | $-13M | $-6M | |
| Interest Income | · | $13.9K | · | · | · | $12.6K | $6.0K | $40.1K | · | · | $64.5K | $85.7K | · | · | $55.5K | $36.7K | |
| Other Non-op | $-929.4K | · | · | · | $16.9K | · | · | · | $71.7K | $83.2K | · | · | $101.9K | $83.5K | · | · | |
| Pretax Income | · | $-3M | · | · | · | $-3M | · | · | $-3M | · | · | · | $-3M | $-4M | $-13M | $-6M | |
| Net Income | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-4M | $-13M | $-6M | |
| EPS (Basic) | $-1.19 | $-1.29 | $-9.74 | $-0.07 | $-6.26 | $-7.58 | $-93.63 | $-1.03 | $-1.01 | $-1.11 | $-1.47 | $-1.54 | $-1.94 | $-3.53 | $-33.16 | $-0.37 | |
| EPS (Diluted) | $-1.19 | $-1.29 | $-9.74 | $-0.07 | $-6.26 | $-7.58 | $-93.63 | $-1.03 | $-1.01 | $-1.11 | $-1.47 | $-1.54 | $-1.94 | $-3.53 | $-33.15 | $-0.37 | |
| Shares (Basic) | 2,750,742 | 2,623,143 | · | 47,525,522 | 628,796 | 373,967 | · | 3,275,998 | 2,983,283 | 2,466,523 | · | 1,350,188 | 1,346,808 | 1,138,573 | · | 16,200,222 | |
| Shares (Diluted) | 2,750,742 | 2,623,143 | · | 47,525,522 | 628,796 | 373,967 | · | 3,275,998 | 2,983,283 | 2,466,523 | · | 1,350,188 | 1,346,808 | 1,138,573 | · | 16,200,222 | |
| EBITDA | $-2M | $-3M | · | $-3M | $-4M | $-3M | · | $-3M | $-3M | $-3M | · | $-2M | $-3M | $-4M | · | $-6M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $196.3K | $2M | $6M | $6M | $7M | $3M | $1M | $3M | $6M | $9M | $5M | $7M | $9M | $11M | $7M | $9M | |
| Prepaid Expense | $1M | $247.4K | $133.9K | $278.3K | $217.2K | $860.8K | $687.8K | $2M | $2M | $857.6K | $926.3K | $1M | $1M | $1M | $2M | $2M | |
| Current Assets | $2M | $2M | $6M | $7M | $7M | $4M | $2M | $5M | $7M | $10M | $6M | $8M | $10M | $12M | $8M | $11M | |
| PP&E (Net) | $3.2K | $3.5K | $3.8K | $4.1K | · | · | $5.0K | $5.3K | $2.3K | $2.4K | $2.6K | $2.7K | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $7M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $172.6K | $193.1K | $213.3K | $5.5K | $8M | |
| Total Assets | $2M | $5M | $8M | $8M | $8M | $5M | $3M | $5M | $8M | $10M | $6M | $8M | $10M | $12M | $9M | $19M | |
| Accounts Payable | $2M | $840.4K | $1M | $727.2K | $785.8K | $552.6K | $880.9K | $711.7K | $953.1K | $455.4K | $311.6K | $346.3K | $239.0K | $316.7K | $327.5K | $311.1K | |
| Accrued Liabilities | $727.5K | $1M | $1M | $1M | $1M | $680.7K | $578.7K | $412.8K | $505.4K | $465.6K | $146.3K | $202.2K | $311.5K | $2M | $403.1K | $216.4K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $2M | $1M | $730.6K | $826.1K | $821.4K | $2M | $998.6K | $1M | |
| Capital Leases | · | · | · | · | · | · | · | · | $21.8K | $44.6K | · | $88.8K | $109.3K | $129.4K | $150.6K | $171.7K | |
| Total Liabilities | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $2M | $1M | $797.5K | $914.8K | $930.7K | $2M | $1M | $1M | |
| Common Stock | $279 | $269 | $257 | $5.3K | $4.0K | $527 | $15 | $327 | $287 | $286 | $129 | $2.5K | $2.5K | $2.5K | $80 | $1.6K | |
| Retained Earnings | $-107M | $-104M | $-101M | $-97M | $-94M | $-90M | $-87M | $-84M | $-81M | $-78M | $-75M | $-73M | $-71M | $-68M | $-64M | $-51M | |
| Treasury Stock | · | · | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | |
| Stockholders' Equity | $-317.3K | $3M | $6M | $6M | $6M | $4M | $2M | $4M | $6M | $9M | $5M | $7M | $9M | $10M | $7M | $17M | |
| Liabilities + Equity | $2M | $5M | $8M | $8M | $8M | $5M | $3M | $5M | $8M | $10M | $6M | $8M | $10M | $12M | $9M | $19M | |
| Shares Outstanding | 2,793,386 | 2,677,835 | 2,571,914 | 52,862,926 | 40,284,356 | 5,269,240 | 148,108 | 3,266,944 | 2,868,883 | 2,855,981 | 1,286,000 | 24,631,474 | 24,531,474 | 24,531,474 | 801,774 | 15,895,087 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $92.1K | $96.0K | $123.5K | $303.0K | $203.3K | $227.7K | $155.0K | $154.2K | $152.6K | $167.6K | $256.8K | $142.9K | $319.1K | $341.5K | $3M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $197.1K | $197.1K | |
| Operating Cash Flow | $-2M | $-4M | $-3M | $-3M | $-2M | $-3M | $-2M | $-4M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Investing Cash Flow | $186.0K | $-500.0K | · | · | · | · | $0 | · | · | · | $0 | · | · | · | · | · | |
| Stock Issued | $315.2K | $245.1K | · | · | $6M | $4M | $549.4K | $931.3K | $0 | $6M | $-30.6K | $0 | $0 | $6M | · | · | |
| Net Stock Activity | · | $245.1K | · | · | · | $4M | · | · | · | $6M | · | · | · | $6M | · | · | |
| Financing Cash Flow | $315.2K | $244.8K | $3M | $3M | $6M | $4M | $547.6K | $926.2K | $-3.4K | $6M | $-30.6K | $-52.7K | $0 | $6M | $-53.6K | $-35.2K | |
| Net Change in Cash | $-1M | $-4M | $-771.5K | $-628.2K | $4M | $2M | $-2M | $-3M | $-3M | $4M | $-2M | $-2M | $-2M | $4M | $-3M | $-3M |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -63.7% | -72.4% | · | -54.9% | -49.9% | -38.4% | · | -52.0% | -34.0% | -24.4% | · | -15.6% | -16.5% | -21.9% | · | -25.3% | |
| ROE | -112.8% | -111.3% | · | -71.9% | -64.9% | -45.7% | · | -62.2% | -39.6% | -28.7% | · | -17.1% | -17.9% | -24.1% | · | -27.1% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 1.0 | · | 3.8 | 3.4 | 2.9 | · | 4.0 | 4.8 | 9.7 | · | 9.6 | 12.0 | 5.7 | · | 9.1 | |
| Quick Ratio | 0.1 | 0.9 | · | 3.6 | 3.3 | 2.3 | · | 2.4 | 3.6 | 8.8 | · | 8.3 | 10.6 | 5.0 | · | 7.6 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.11 | $0.95 | · | $0.11 | $0.15 | $0.67 | · | $1.14 | $2.10 | $3.11 | · | $0.29 | $0.37 | $0.41 | · | $1.08 | |
| Cash Flow / Share | · | $-1.37 | · | · | · | $-0.29 | · | · | · | $-0.83 | · | · | · | · | · | · | |
| Cash / Share | $0.07 | $0.63 | · | $0.12 | $0.17 | $0.55 | · | $0.89 | $1.94 | $3.12 | · | $0.28 | $0.35 | $0.44 | · | $0.57 | |
| EPS (TTM) | $-12.29 | $-17.36 | · | $-107.54 | $-108.50 | $-103.25 | · | $-4.62 | $-5.13 | $-6.06 | · | $-40.16 | $-38.99 | $-37.37 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-13M | $-14M | · | $-13M | $-13M | $-12M | · | $-12M | $-10M | $-10M | · | $-22M | $-26M | $-28M | · | $-18M | |
| Market Cap | $5M | $7M | · | $10M | $8M | $2M | · | $4M | $6M | $7M | · | $123M | $244M | $245M | · | $718M | |
| P/E | -0.2 | -0.1 | · | -0.0 | -0.0 | -0.1 | · | -7.4 | -10.9 | -9.8 | · | -3.1 | -6.4 | -6.7 | · | · | |
| P/B | -16.9 | 2.7 | · | 1.7 | 1.4 | 0.6 | · | 1.2 | 1.1 | 0.8 | · | 17.2 | 26.7 | 24.2 | · | 41.7 | |
| P / Tangible Book | · | 2.7 | · | 1.7 | 1.4 | 0.6 | · | 1.2 | 1.1 | 0.8 | · | 17.2 | 26.7 | 24.2 | · | 73.5 | |
| P / Cash Flow | · | -1.9 | · | · | · | -0.7 | · | · | · | -3.3 | · | · | · | -116.0 | · | · | |
| Earnings Yield | -640.1% | -687.5% | · | -2240.4% | -2117.1% | -1116.2% | · | -13.5% | -9.2% | -10.2% | · | -32.1% | -15.7% | -14.9% | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | · | · | · | $0 | $0 |
| Net Gelir | $-14M | $-12M | $-11M | $-27M | $-11M |
| Seyreltilmiş Hisse Başı Kâr | $-10.36 | $-96.78 | $-8.48 | $-34.05 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | · | 1.2 | 7.7 | 8.4 | · |
| Cari Oran | · | 0.8 | 6.4 | 6.5 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | $-11M | $-8M | · | · |
Kurumsal Sahipler (13F) 13 dosya · $566K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
13
Tutulan Değer
$566K
Yeni pozisyonlar
4
Çıkan pozisyonlar
2
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 4 (0 önceki Ç'ye göre) | 2 (-1 önceki Ç'ye göre) | 3 (+1 önceki Ç'ye göre) | 1 (-1 önceki Ç'ye göre) | +78K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Connective Capital Management, LLC | $163.726 | 85.274 | 28,91% | Hisse senetleri |
| Stonepine Capital Management, LLC | $105.600 | 55.000 | 18,65% | Hisse senetleri |
| VANGUARD GROUP INC | $67.928 | 23.586 | 12,00% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $42.412 | 22.090 | 7,49% | Hisse senetleri |
| CITADEL ADVISORS LLC | $40.908 | 21.306 | 7,22% | Hisse senetleri |
| StoneX Group Inc. | $29.623 | 11.437 | 5,23% | Hisse senetleri |
| XTX Topco Ltd | $25.521 | 13.292 | 4,51% | Hisse senetleri |
| JANE STREET GROUP, LLC | $25.466 | 13.264 | 4,50% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $24.440 | 12.729 | 4,32% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $20.845 | 10.857 | 3,68% | Hisse senetleri |
| UBS Group AG | $14.964 | 7.794 | 2,64% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $4.798 | 2.499 | 0,85% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $13 | 7 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| HX Entertainment Ltd ×3 başvurular | 23 Şubat 2026 | 13,00% | Değişiklik | Pasif yatırım | SEC |
| David Young, CorLyst, LLC | 13 Ekim 2020 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 16 içeriden öğrenenler · 7 yöneticiler · 8 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Russell Skibsted | Chief Financial Officer | 26 Temmuz 2026 A | 16.689 | 7 | 0 | $41.685 |
| James H Stanker | Chief Financial Officer | 28 Haziran 2024 A | 6.482 | 0 | 0 | $0 |
| Robert Michael Floyd | Chief Operating Officer | 09 Şubat 2023 A | 82.267 | 0 | 0 | $0 |
| Patrick Lin | Chief Business - Strategy Off | 26 Temmuz 2026 A | 13.113 | 7 | 0 | $28.465 |
| Wendy Guy | Chief Administrative Officer | 26 Temmuz 2026 A | 14.394 | 7 | 0 | $32.919 |
| David Young | Pres. Research & Development | 30 Haziran 2026 P | 21.729 | 7 | 0 | $32.428 |
| Sian Bigora | Chief Development Officer | 30 Nisan 2026 P | 7.481 | 4 | 0 | $21.378 |
| Sheila Gujrathi | Yönetim kurulu üyesi | 28 Temmuz 2026 A | · | 0 | 0 | $0 |
| Geraldine Pannu | Yönetim kurulu üyesi | 26 Temmuz 2026 A | 2.391 | 1 | 0 | $5.263 |
| Khoso Baluch | Yönetim kurulu üyesi | 26 Temmuz 2026 A | 2.528 | 1 | 0 | $5.763 |
| James R Neal | Yönetim kurulu üyesi | 26 Temmuz 2026 A | 1.021 | 1 | 0 | $2.004 |
| Justin W Yorke | Yönetim kurulu üyesi | 26 Temmuz 2026 A | 353 | 0 | 0 | $0 |
| Virgil Thompson | Yönetim kurulu üyesi | 27 Haziran 2023 A | 123.849 | 0 | 0 | $0 |
| Khalid Islam | Yönetim kurulu üyesi | 01 Ocak 2022 A | 72.486 | 0 | 0 | $0 |
| George K Ng | · | 08 Ağustos 2026 M | 17.092 | 10 | 0 | $55.061 |
| James E. Besser | · | 08 Nisan 2021 S | 648.300 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 12.729 SH | 19 Ağustos 2026 | Günlük |
PCSA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
AL
2 28,6%
Güçlü Al
4 57,1%
Al
1 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026